EVEREST MED(01952.HK)

Event Tracking

Apr7

Ever Sea Medicines (Singapore) Pte. Ltd., a wholly-owned subsidiary of CanSino, Acquires 100% of the Issued Share Capital and Related Assets of HASTEN BIOPHARMACEUTICALS (SG) PTE. LTD.

23:55

Mar28

Innubeay 2025 Announces Full Year Revenue of 1.707 billion Yuan and Publishes Annual Report

12:06

Mar25

EVEREST MED released FY2025 Q3 earnings on March 25 (BJT), actual revenue HKD 689 M, actual EPS HKD -0.0781

15:00

EVEREST MED released FY2025 9 Months Earnings on March 25, 2026 (BJT), with actual revenue of HKD 1.172 B and EPS of HKD -0.9092

15:00

EVEREST MED released FY2025 Q4 earnings on March 25 After-Market (BJT), actual revenue HKD 700.89 M, actual EPS HKD -0.0776

11:00

EVEREST MED released FY2025 Annual Earnings on March 25 After-Market (BJT), actual revenue HKD 1.865 B (forecast HKD 1.873 B), actual EPS HKD -0.9727 (forecast HKD -0.5476)

11:00